Comparison of Cellular and Transcriptional Responses to 1,25-Dihydroxyvitamin D3 and Glucocorticoids in Peripheral Blood Mononuclear Cells
- 1. University of Chicago
Description
Glucocorticoids (GC) and 1,25-dihydroxyvitamin D3 (1,25(OH)2 D3) are steroid hormones with anti-inflammatory properties with enhanced effects when combined. We previously showed that transcriptional response to GCs was correlated with inter-individual and inter-ethnic cellular response. Here, we profiled cellular and transcriptional responses to 1,25(OH)2 D3 from the same donors. We studied cellular response to combined treatment with GCs and 1,25(OH)2 D3 in a subset of individuals least responsive to GCs. We found that combination treatment had significantly greater inhibition of proliferation than with either steroid hormone alone. Overlapping differentially expressed (DE) genes between the two hormones were enriched for adaptive and innate immune processes. Non-overlapping differentially expressed genes with 1,25(OH)2 D3 treatment were enriched for pathways involving the electron transport chain, while with GC treatment, non-overlapping genes were enriched for RNA-related processes. These results suggest that 1,25(OH)2 D3 enhances GC anti-inflammatory properties through a number of shared and non-shared transcriptionally-mediated pathways.
Files
journal.pone.0076643.pdf
Files
(2.3 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:24a000a8053996a0685412d175c81c7e |
2.1 MB | Preview Download |
|
md5:1ba41566bfcf6947611ef6ec10b9b1e8
|
269.0 kB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0076643
- Other
- oai:uchicago.tind.io:10541
Funding
- Unknown funder
- K08 CA142892
- Unknown funder
- R01 GM101682
- Unknown funder
- Digestive Disease Research Core Center pilot and feasibility funding
- Unknown funder
- Clinical Therapeutics training grant